These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25921617)

  • 21. Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion.
    Barth BK; Fischer MA; Kambakamba P; Lesurtel M; Reiner CS
    Eur J Radiol; 2016 Apr; 85(4):843-9. PubMed ID: 26971433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing signal intensity correction during evaluation of hepatic parenchymal enhancement on gadoxetate disodium-enhanced MRI: comparison of three methods.
    Onoda M; Hyodo T; Murakami T; Okada M; Uto T; Hori M; Miyati T
    Eur J Radiol; 2015 Mar; 84(3):339-345. PubMed ID: 25543887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
    Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
    J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.
    Feuerlein S; Boll DT; Gupta RT; Ringe KI; Marin D; Merkle EM
    AJR Am J Roentgenol; 2011 Jan; 196(1):W18-24. PubMed ID: 21178026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
    Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
    World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional magnetic resonance cholangiography enhanced with Gd-EOB-DTPA: effect of liver function on biliary system visualization.
    Feng ST; Wu L; Chan T; Cai H; Luo Y; Zheng K; Tang D; Li ZP
    J Magn Reson Imaging; 2014 May; 39(5):1254-8. PubMed ID: 24115466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
    Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
    J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
    Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
    AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
    Ding Y; Rao SX; Chen C; Li R; Zeng MS
    Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
    Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
    Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.
    Fujinaga Y; Ohya A; Matsushita T; Kurozumi M; Ueda K; Kitou Y; Ueda H; Kadoya M
    Jpn J Radiol; 2011 Dec; 29(10):695-700. PubMed ID: 22009420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
    Ma C; Liu A; Wang Y; Geng X; Hao L; Song Q; Sun B; Wang H; Zhao G
    Life Sci; 2014 Jul; 108(2):104-8. PubMed ID: 24881519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.